MicroRNA-29b/graphene oxide-polyethyleneglycol-polyethylenimine complex incorporated within chitosan hydrogel

Han Qin1,2,3, Yujie Ji1,2,3, Guangyue Li1,2,3

  • 1College of Stomatology, Chongqing Medical University, Chongqing, China.

Frontiers in Chemistry
|August 8, 2022
PubMed

Insights

This study developed a novel graphene oxide (GO) nanocomplex to deliver microRNA-29b (miR-29b) for enhanced bone regeneration. The miR-29b/GO-PEG-PEI composite hydrogel effectively promoted bone marrow mesenchymal stem cell (BMSC) osteogenic differentiation and bone repair in vivo.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Nanotechnology

Background:

  • MicroRNAs (miRNAs) are crucial regulators of bone marrow mesenchymal stem cell (BMSC) osteogenic differentiation.
  • Unmodified miRNAs are unstable and cannot efficiently cross cell membranes, limiting their therapeutic use.
  • Graphene oxide (GO)-based nanomaterials offer a promising platform for gene delivery due to their unique properties.

Purpose of the Study:

  • To develop a functionalized GO-based nanocomplex for efficient delivery of miR-29b.
  • To evaluate the potential of miR-29b loaded into a chitosan (CS) hydrogel for promoting osteogenesis and bone regeneration.

Main Methods:

  • Preparation of a polyethyleneglycol (PEG) and polyethylenimine (PEI) functionalized GO nanocomplex for miR-29b loading.
  • Encapsulation of the miR-29b/GO-PEG-PEI nanocomplex into a chitosan (CS) hydrogel.
  • In vitro and in vivo evaluation of the composite hydrogel's efficacy in promoting BMSC osteogenic differentiation and bone regeneration.

Main Results:

  • The GO-PEG-PEI nanocomplex demonstrated good biocompatibility, miRNA loading capacity, and transfection efficiency.
  • The miR-29b/GO-PEG-PEI@CS composite hydrogel successfully promoted BMSC osteogenic differentiation.
  • In vivo studies confirmed the hydrogel's ability to enhance bone regeneration.

Conclusions:

  • Functionalized GO serves as a promising carrier for miRNA delivery.
  • The miR-29b/GO-PEG-PEI@CS hydrogel holds significant potential for treating bone defects through enhanced osteogenesis and regeneration.

Related Concept Videos